Quest Diagnostics Pre-Paid Expenses 2010-2025 | DGX

Quest Diagnostics pre-paid expenses for the quarter ending March 31, 2025 were $294M, a 17.13% increase year-over-year.

  • Quest Diagnostics pre-paid expenses for 2024 were $0.351B, a 22.73% increase from 2023.
  • Quest Diagnostics pre-paid expenses for 2023 were $0.286B, a 45.92% increase from 2022.
  • Quest Diagnostics pre-paid expenses for 2022 were $0.196B, a 12.11% decline from 2021.

Quest Diagnostics Pre-Paid Expenses 2010-2025 | DGX

  • Quest Diagnostics pre-paid expenses for 2024 were $0.351B, a 22.73% increase from 2023.
  • Quest Diagnostics pre-paid expenses for 2023 were $0.286B, a 45.92% increase from 2022.
  • Quest Diagnostics pre-paid expenses for 2022 were $0.196B, a 12.11% decline from 2021.
Related Stocks
Company NameMarket
Cap
Encompass Health (EHC)$11.1B
DaVita (DVA)$10.7B
Elanco Animal Health (ELAN)$7.3B
Chemed (CHE)$6.6B
Option Care Health (OPCH)$4.8B
RadNet (RDNT)$4.3B
Amedisys (AMED)$3.2B
Addus HomeCare (ADUS)$2B
LifeStance Health (LFST)$1.6B
Astrana Health (ASTH)$1.3B
U.S Physical Therapy (USPH)$1.1B
Pennant (PNTG)$808M
Aveanna Healthcare Holdings (AVAH)$773M
Atai Life Sciences (ATAI)$647M
Daxor (DXR)$44M
MEDIROM Healthcare Technologies (MRM)$39M
Ontrak (OTRK)$2M
Psychemedics (PMD)$0M